Cell biology

Antidiabetic agent could smother pancreatic cancer stem cells

Metformin, commonly used for diabetes, was found to shut down metabolism in pancreatic cancer stem cells, which can spread cancer around the body.…

Asthma therapies get personal

A new crop of biologic drugs promises to usher asthma treatment into the realm of personalised medicine.…

Local anaesthetics can affect tooth development in children

Local anaesthetics routinely given to children undergoing dental treatment may affect tooth cell growth and development.…

Scientists find another link between aspirin and cancer treatment

A study by UK researchers has found a possible explanation for a reported link between aspirin and a reduced risk of cancer.…

Opioid drugs produced from engineered strain of yeast

Researchers have successfully introduced the enzymes needed to synthesise opioids into a strain of engineered yeast, which could be used as an alternative opioid source to the poppy.…

Scientists develop hydrogel to directly target disease sites in inflammatory bowel disease

Researchers have developed a hydrogel that selectively delivers drugs to inflamed tissue, which could pave the way for improved treatment options for patients with inflammatory bowel disease, according to a study published in Science Translational Medicine.…

Glaucoma treatment may counter the virulence of tuberculosis

Researchers screened compounds that inhibit the way Mycobacterium tuberculosis  adapts to its environment in a host.…

Childhood antibiotic exposure linked with development of juvenile idiopathic arthritis

Researchers have analysed health records of children in the UK and concluded that antibiotics may play a role in the pathogenesis of juvenile idiopathic arthritis.…

Clinical Pharmacist’s monthly news round-up: the top 10 in the past month

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…

Progesterone receptor could slow breast cancer growth

Researchers have discovered why breast cancer patients whose tumours display both oestrogen and progesterone receptors have the best chance of survival.…